. . . "Neuromuscular-blocking drug"@en . . . . . "\u0645\u062D\u0635\u0631 \u0639\u0636\u0644\u064A \u0639\u0635\u0628\u064A"@ar . . . . "Los f\u00E1rmacos que pertenecen a la categor\u00EDa de bloqueadores neuromusculares tienen como finalidad relajar los m\u00FAsculos inhibiendo la contracci\u00F3n del m\u00FAsculo esquel\u00E9tico al interferir con el funcionamiento entre la neurona y el m\u00FAsculo mismo. El bloqueo de la transmisi\u00F3n neuromuscular a nivel de la sinapsis neuromuscular, causa par\u00E1lisis del m\u00FAsculo esquel\u00E9tico afectado. Ello se logra por acci\u00F3n presin\u00E1ptica por inhibici\u00F3n de la s\u00EDntesis o liberaci\u00F3n de acetilcolina o por acci\u00F3n a nivel del receptor colin\u00E9rgico. Aunque existen drogas que act\u00FAan a nivel presin\u00E1ptico (como la toxina botul\u00EDnica y la tetrodotoxina), los medicamentos cl\u00EDnicamente relevantes act\u00FAan a nivel postsin\u00E1ptico.\u200B"@es . . . . . . . . . "Blocador neuromuscular"@ca . . . . . . . . . "Els blocadors neuromusculars s\u00F3n subst\u00E0ncies que inhibeixen la contracci\u00F3 de la fibra muscular estriada esquel\u00E8tica per blocatge dels receptors nicot\u00EDnics a nivell de la . Tamb\u00E9 s\u00F3n anomenats relaxants musculars."@ca . "2729485"^^ . . "Depolaryzuj\u0105ce \u015Brodki zwiotczaj\u0105ce, pseudokuraryny, leptokuraryny \u2013 leki zwiotczaj\u0105ce o depolaryzacyjnym mechanizmie dzia\u0142ania, syntetyczne substancje blokuj\u0105ce zdolno\u015B\u0107 prawid\u0142owej reakcji mi\u0119\u015Bni szkieletowych na pobudzenie nerwowe, wywo\u0142uj\u0105ce w konsekwencji zwiotczenie mi\u0119\u015Bni. S\u0105 u\u017Cywane w chirurgii do parali\u017Cowania mi\u0119\u015Bni podczas operacji, podczas nastawiania zwichni\u0119\u0107 i z\u0142ama\u0144 oraz w niekt\u00F3rych zabiegach diagnostycznych (na przyk\u0142ad endoskopii). Przedstawicielem tych \u015Brodk\u00F3w jest chlorek suksametoniowy \u2013 du\u017Co stabilniejsza od acetylocholiny pochodna choliny, powoli rozk\u0142adana przez acetylocholinoesteraz\u0119."@pl . . . . . . . . "Los f\u00E1rmacos que pertenecen a la categor\u00EDa de bloqueadores neuromusculares tienen como finalidad relajar los m\u00FAsculos inhibiendo la contracci\u00F3n del m\u00FAsculo esquel\u00E9tico al interferir con el funcionamiento entre la neurona y el m\u00FAsculo mismo. El bloqueo de la transmisi\u00F3n neuromuscular a nivel de la sinapsis neuromuscular, causa par\u00E1lisis del m\u00FAsculo esquel\u00E9tico afectado. Ello se logra por acci\u00F3n presin\u00E1ptica por inhibici\u00F3n de la s\u00EDntesis o liberaci\u00F3n de acetilcolina o por acci\u00F3n a nivel del receptor colin\u00E9rgico. Aunque existen drogas que act\u00FAan a nivel presin\u00E1ptico (como la toxina botul\u00EDnica y la tetrodotoxina), los medicamentos cl\u00EDnicamente relevantes act\u00FAan a nivel postsin\u00E1ptico.\u200B"@es . . . . . . . . . . "\u795E\u7ECF\u808C\u8089\u963B\u6EDE\u836F\uFF08Neuromuscular-blocking drugs\uFF09\u662F\u53EF\u4EE5\u963B\u6EDE\u795E\u7ECF\u808C\u8089\u63A5\u70B9\u795E\u7D93\u50B3\u5C0E\u7684\u85E5\u7269\uFF0C\u6703\u9020\u6210\u9AA8\u9ABC\u808C\u7684\u762B\u75EA\u3002\u53EF\u4EE5\u900F\u904E\u5728\u4F5C\u7528\uFF0C\u6291\u5236\u4E59\u9170\u80C6\u78B1\uFF08ACh\uFF09\u7684\u5408\u6210\u6216\u662F\u91CB\u653E\u4F86\u9054\u6210\uFF0C\u4E5F\u53EF\u4EE5\u5728\u4F5C\u7528\uFF0C\u6291\u5236\u904B\u52D5\u795E\u7D93\u7D42\u677F\u7684\u4E59\u9170\u80C6\u78B1\u53D7\u4F53\u3002\u6709\u4E9B\u85E5\u7269\uFF08\u4F8B\u5982\u8089\u6BD2\u687F\u83CC\u6BD2\u7D20\u53CA\uFF09\u662F\u5728\u7A81\u89F8\u524D\u4F5C\u7528\uFF0C\u4E0D\u904E\u81E8\u5E8A\u4E0A\u5E38\u7528\u7684\u85E5\u7269\u4E3B\u8981\u662F\u5728\u7A81\u89F8\u5F8C\u4F5C\u7528\u3002"@zh . "\u0627\u0644\u062D\u0627\u0635\u0631\u0627\u062A \u0627\u0644\u0639\u0636\u0644\u064A\u0629 \u0627\u0644\u0639\u0635\u0628\u064A\u0629 \u0647\u064A \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u062A\u064A \u062A\u062D\u0635\u0631 \u0627\u0644\u0646\u0642\u0644 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0641\u064A \u0627\u0644\u0645\u0648\u0635\u0644 \u0627\u0644\u0639\u0635\u0628\u064A \u0627\u0644\u0639\u0636\u0644\u064A\u060C \u0645\u0624\u062F\u064A\u0629 \u0625\u0644\u0649 \u0634\u0644\u0644 \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0647\u064A\u0643\u0644\u064A\u0629 \u0627\u0644\u0645\u062A\u0623\u062B\u0631\u0629. \u064A\u062D\u062F\u062B \u0647\u0630\u0627 \u0639\u0628\u0631 \u062A\u0623\u062B\u064A\u0631\u0647\u0627 \u0641\u064A \u0645\u0633\u062A\u0642\u0628\u0644\u0627\u062A \u0627\u0644\u0623\u0633\u062A\u064A\u0644 \u0643\u0648\u0644\u064A\u0646 (\u0625\u0646 \u0625\u0645) \u0628\u0639\u062F \u0627\u0644\u0645\u0634\u0628\u0643\u064A\u0629. \u0641\u064A \u0627\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u060C \u064A\u064F\u0633\u062A\u062E\u062F\u0645 \u0627\u0644\u0645\u062D\u0635\u0631 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0628\u0627\u0644\u062A\u0631\u0627\u0641\u0642 \u0645\u0639 \u0627\u0644\u062A\u062E\u062F\u064A\u0631 \u0645\u0646 \u0623\u062C\u0644 \u0625\u0646\u062A\u0627\u062C \u0627\u0644\u0634\u0644\u0644\u060C \u0644\u0634\u0644 \u0627\u0644\u062D\u0628\u0627\u0644 \u0627\u0644\u0635\u0648\u062A\u064A\u0629 \u0628\u0647\u062F\u0641 \u062A\u0646\u0628\u064A\u0628 \u0627\u0644\u0631\u063A\u0627\u0645\u0649 \u0645\u0646 \u062C\u0647\u0629\u060C \u0648\u062A\u062D\u0633\u064A\u0646 \u0627\u0644\u0633\u0627\u062D\u0629 \u0627\u0644\u062C\u0631\u0627\u062D\u064A\u0629 \u0645\u0646 \u062E\u0644\u0627\u0644 \u062A\u062B\u0628\u064A\u0637 \u0627\u0644\u062A\u0647\u0648\u064A\u0629 \u0627\u0644\u062A\u0644\u0642\u0627\u0626\u064A\u0629 \u0648\u0627\u0633\u062A\u0631\u062E\u0627\u0621 \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0647\u064A\u0643\u0644\u064A\u0629 \u0645\u0646 \u062C\u0647\u0629 \u0623\u062E\u0631\u0649. \u0646\u0638\u0631\u064B\u0627 \u0625\u0644\u0649 \u062A\u0623\u062B\u064A\u0631 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0645\u0646\u0627\u0633\u0628\u0629 \u0645\u0646 \u0627\u0644\u062F\u0648\u0627\u0621 \u0627\u0644\u0645\u062D\u0635\u0631 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0644\u0627\u0632\u0645\u0629 \u0644\u0644\u062A\u0646\u0641\u0633 \u0645\u0624\u062F\u064A\u064B\u0627 \u0625\u0644\u0649 \u0634\u0644\u0647\u0627 (\u0623\u064A \u0627\u0644\u062D\u062C\u0627\u0628 \u0627\u0644\u062D\u0627\u062C\u0632)\u060C \u064A\u062C\u0628 \u062A\u0648\u0641\u0631 \u0627\u0644\u062A\u0647\u0648\u064A\u0629 \u0627\u0644\u0645\u064A\u0643\u0627\u0646\u064A\u0643\u064A\u0629 \u0645\u0646 \u0623\u062C\u0644 \u0627\u0644\u062D\u0641\u0627\u0638 \u0639\u0644\u0649 \u0627\u0644\u062A\u0646\u0641\u0633 \u0627\u0644\u0643\u0627\u0641\u064A. \u064A\u0628\u0642\u0649 \u0627\u0644\u0645\u0631\u064A\u0636 \u0639\u0644\u0649 \u0648\u0639\u064A \u0628\u0627\u0644\u0623\u0644\u0645 \u062D\u062A\u0649 \u0628\u0639\u062F \u062D\u062F\u0648\u062B \u062D\u0635\u0631 \u062A\u0648\u0635\u064A\u0644 \u0643\u0627\u0645\u0644\u061B \u0628\u0627\u0644\u062A\u0627\u0644\u064A\u060C \u064A\u062C\u0628 \u0625\u0639\u0637\u0627\u0621 \u0627\u0644\u0645\u062E\u062F\u0631\u0627\u062A \u0627\u0644\u0639\u0627\u0645\u0629 \u0648/\u0623\u0648 \u0645\u0633\u0643\u0646\u0627\u062A \u0627\u0644\u0623\u0644\u0645 \u0645\u0646 \u0623\u062C\u0644 \u0643\u0628\u062D \u0627\u0644\u0648\u0639\u064A \u062A\u062D\u062A \u0627\u0644\u062A\u062E\u062F\u064A\u0631."@ar . . . . . . . . . . "Bloqueador neuromuscular \u00E9 uma droga que interrompe ou simula a transmiss\u00E3o dos impulsos nervosos na jun\u00E7\u00E3o neuromuscular esquel\u00E9tica, causando paralisia dos m\u00FAsculos esquel\u00E9ticos afetados. Isto \u00E9 conseguido, quer pela atua\u00E7\u00E3o pr\u00E9-sin\u00E1ptica atrav\u00E9s da inibi\u00E7\u00E3o da s\u00EDntese ou libera\u00E7\u00E3o de acetilcolina (ACh), ou agindo p\u00F3s-sinapticamente no receptor de acetilcolina. Embora existam drogas que atuam pr\u00E9-sinapticamente (tais como a toxina botul\u00EDnica e tetrodotoxina), os bloqueadores neuromusculares clinicamente relevante atuam p\u00F3s-sinapticamente. Os principais bloqueadores neuromusculares usados no Brasil para os procedimentos cir\u00FArgicos eletivos s\u00E3o rocur\u00F4nio,atrac\u00FArio e cisatrac\u00FArio."@pt . . . "Bloqueador neuromuscular \u00E9 uma droga que interrompe ou simula a transmiss\u00E3o dos impulsos nervosos na jun\u00E7\u00E3o neuromuscular esquel\u00E9tica, causando paralisia dos m\u00FAsculos esquel\u00E9ticos afetados. Isto \u00E9 conseguido, quer pela atua\u00E7\u00E3o pr\u00E9-sin\u00E1ptica atrav\u00E9s da inibi\u00E7\u00E3o da s\u00EDntese ou libera\u00E7\u00E3o de acetilcolina (ACh), ou agindo p\u00F3s-sinapticamente no receptor de acetilcolina. Embora existam drogas que atuam pr\u00E9-sinapticamente (tais como a toxina botul\u00EDnica e tetrodotoxina), os bloqueadores neuromusculares clinicamente relevante atuam p\u00F3s-sinapticamente. Os principais bloqueadores neuromusculares usados no Brasil para os procedimentos cir\u00FArgicos eletivos s\u00E3o rocur\u00F4nio,atrac\u00FArio e cisatrac\u00FArio. Clinicamente, o bloqueio neuromuscular \u00E9 usado como um adjuvante \u00E0 anestesia para induzir paralisia muscular, de modo que a cirurgia, especialmente intra-abdominal e intra-operat\u00F3rio de cirurgias tor\u00E1cicas, possam ser realizadas com menos complica\u00E7\u00F5es. Como o bloqueio neuromuscular pode paralisar os m\u00FAsculos necess\u00E1rios para a respira\u00E7\u00E3o, dispositivos de ventila\u00E7\u00E3o mec\u00E2nica devem estar sempre dispon\u00EDveis para manter a respira\u00E7\u00E3o adequada. Como os pacientes ainda sentem dor mesmo ap\u00F3s o bloqueio de condu\u00E7\u00E3o ter sido feito, anest\u00E9sicos gerais e/ou analg\u00E9sicos devem ser administrados."@pt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "\u795E\u7ECF\u808C\u8089\u963B\u6EDE\u836F"@zh . "Depolaryzuj\u0105ce \u015Brodki zwiotczaj\u0105ce"@pl . . . . . . . . . . "\u795E\u7ECF\u808C\u8089\u963B\u6EDE\u836F\uFF08Neuromuscular-blocking drugs\uFF09\u662F\u53EF\u4EE5\u963B\u6EDE\u795E\u7ECF\u808C\u8089\u63A5\u70B9\u795E\u7D93\u50B3\u5C0E\u7684\u85E5\u7269\uFF0C\u6703\u9020\u6210\u9AA8\u9ABC\u808C\u7684\u762B\u75EA\u3002\u53EF\u4EE5\u900F\u904E\u5728\u4F5C\u7528\uFF0C\u6291\u5236\u4E59\u9170\u80C6\u78B1\uFF08ACh\uFF09\u7684\u5408\u6210\u6216\u662F\u91CB\u653E\u4F86\u9054\u6210\uFF0C\u4E5F\u53EF\u4EE5\u5728\u4F5C\u7528\uFF0C\u6291\u5236\u904B\u52D5\u795E\u7D93\u7D42\u677F\u7684\u4E59\u9170\u80C6\u78B1\u53D7\u4F53\u3002\u6709\u4E9B\u85E5\u7269\uFF08\u4F8B\u5982\u8089\u6BD2\u687F\u83CC\u6BD2\u7D20\u53CA\uFF09\u662F\u5728\u7A81\u89F8\u524D\u4F5C\u7528\uFF0C\u4E0D\u904E\u81E8\u5E8A\u4E0A\u5E38\u7528\u7684\u85E5\u7269\u4E3B\u8981\u662F\u5728\u7A81\u89F8\u5F8C\u4F5C\u7528\u3002"@zh . . . "Depolaryzuj\u0105ce \u015Brodki zwiotczaj\u0105ce, pseudokuraryny, leptokuraryny \u2013 leki zwiotczaj\u0105ce o depolaryzacyjnym mechanizmie dzia\u0142ania, syntetyczne substancje blokuj\u0105ce zdolno\u015B\u0107 prawid\u0142owej reakcji mi\u0119\u015Bni szkieletowych na pobudzenie nerwowe, wywo\u0142uj\u0105ce w konsekwencji zwiotczenie mi\u0119\u015Bni. S\u0105 u\u017Cywane w chirurgii do parali\u017Cowania mi\u0119\u015Bni podczas operacji, podczas nastawiania zwichni\u0119\u0107 i z\u0142ama\u0144 oraz w niekt\u00F3rych zabiegach diagnostycznych (na przyk\u0142ad endoskopii)."@pl . . . . . . . . . . . . . . . . "Neuromuscular-blocking drugs block neuromuscular transmission at the neuromuscular junction, causing paralysis of the affected skeletal muscles. This is accomplished via their action on the post-synaptic acetylcholine (Nm) receptors. Patients are still aware of pain even after full conduction block has occurred; hence, general anesthetics and/or analgesics must also be given to prevent anesthesia awareness."@en . . . . . . . . . . . . . . . . . . . . . . . "Bloqueador neuromuscular"@pt . . . . . . . . . . . . . "Bloqueador neuromuscular"@es . . "\u0627\u0644\u062D\u0627\u0635\u0631\u0627\u062A \u0627\u0644\u0639\u0636\u0644\u064A\u0629 \u0627\u0644\u0639\u0635\u0628\u064A\u0629 \u0647\u064A \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u062A\u064A \u062A\u062D\u0635\u0631 \u0627\u0644\u0646\u0642\u0644 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0641\u064A \u0627\u0644\u0645\u0648\u0635\u0644 \u0627\u0644\u0639\u0635\u0628\u064A \u0627\u0644\u0639\u0636\u0644\u064A\u060C \u0645\u0624\u062F\u064A\u0629 \u0625\u0644\u0649 \u0634\u0644\u0644 \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0647\u064A\u0643\u0644\u064A\u0629 \u0627\u0644\u0645\u062A\u0623\u062B\u0631\u0629. \u064A\u062D\u062F\u062B \u0647\u0630\u0627 \u0639\u0628\u0631 \u062A\u0623\u062B\u064A\u0631\u0647\u0627 \u0641\u064A \u0645\u0633\u062A\u0642\u0628\u0644\u0627\u062A \u0627\u0644\u0623\u0633\u062A\u064A\u0644 \u0643\u0648\u0644\u064A\u0646 (\u0625\u0646 \u0625\u0645) \u0628\u0639\u062F \u0627\u0644\u0645\u0634\u0628\u0643\u064A\u0629. \u0641\u064A \u0627\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0627\u0644\u0633\u0631\u064A\u0631\u064A\u060C \u064A\u064F\u0633\u062A\u062E\u062F\u0645 \u0627\u0644\u0645\u062D\u0635\u0631 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0628\u0627\u0644\u062A\u0631\u0627\u0641\u0642 \u0645\u0639 \u0627\u0644\u062A\u062E\u062F\u064A\u0631 \u0645\u0646 \u0623\u062C\u0644 \u0625\u0646\u062A\u0627\u062C \u0627\u0644\u0634\u0644\u0644\u060C \u0644\u0634\u0644 \u0627\u0644\u062D\u0628\u0627\u0644 \u0627\u0644\u0635\u0648\u062A\u064A\u0629 \u0628\u0647\u062F\u0641 \u062A\u0646\u0628\u064A\u0628 \u0627\u0644\u0631\u063A\u0627\u0645\u0649 \u0645\u0646 \u062C\u0647\u0629\u060C \u0648\u062A\u062D\u0633\u064A\u0646 \u0627\u0644\u0633\u0627\u062D\u0629 \u0627\u0644\u062C\u0631\u0627\u062D\u064A\u0629 \u0645\u0646 \u062E\u0644\u0627\u0644 \u062A\u062B\u0628\u064A\u0637 \u0627\u0644\u062A\u0647\u0648\u064A\u0629 \u0627\u0644\u062A\u0644\u0642\u0627\u0626\u064A\u0629 \u0648\u0627\u0633\u062A\u0631\u062E\u0627\u0621 \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0647\u064A\u0643\u0644\u064A\u0629 \u0645\u0646 \u062C\u0647\u0629 \u0623\u062E\u0631\u0649. \u0646\u0638\u0631\u064B\u0627 \u0625\u0644\u0649 \u062A\u0623\u062B\u064A\u0631 \u0627\u0644\u062C\u0631\u0639\u0629 \u0627\u0644\u0645\u0646\u0627\u0633\u0628\u0629 \u0645\u0646 \u0627\u0644\u062F\u0648\u0627\u0621 \u0627\u0644\u0645\u062D\u0635\u0631 \u0627\u0644\u0639\u0636\u0644\u064A \u0627\u0644\u0639\u0635\u0628\u064A \u0641\u064A \u0627\u0644\u0639\u0636\u0644\u0627\u062A \u0627\u0644\u0644\u0627\u0632\u0645\u0629 \u0644\u0644\u062A\u0646\u0641\u0633 \u0645\u0624\u062F\u064A\u064B\u0627 \u0625\u0644\u0649 \u0634\u0644\u0647\u0627 (\u0623\u064A \u0627\u0644\u062D\u062C\u0627\u0628 \u0627\u0644\u062D\u0627\u062C\u0632)\u060C \u064A\u062C\u0628 \u062A\u0648\u0641\u0631 \u0627\u0644\u062A\u0647\u0648\u064A\u0629 \u0627\u0644\u0645\u064A\u0643\u0627\u0646\u064A\u0643\u064A\u0629 \u0645\u0646 \u0623\u062C\u0644 \u0627\u0644\u062D\u0641\u0627\u0638 \u0639\u0644\u0649 \u0627\u0644\u062A\u0646\u0641\u0633 \u0627\u0644\u0643\u0627\u0641\u064A."@ar . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Neuromuscular-blocking drugs block neuromuscular transmission at the neuromuscular junction, causing paralysis of the affected skeletal muscles. This is accomplished via their action on the post-synaptic acetylcholine (Nm) receptors. In clinical use, neuromuscular block is used adjunctively to anesthesia to produce paralysis, firstly to paralyze the vocal cords, and permit intubation of the trachea, and secondly to optimize the surgical field by inhibiting spontaneous ventilation, and causing relaxation of skeletal muscles. Because the appropriate dose of neuromuscular-blocking drug may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should be available to maintain adequate respiration. Patients are still aware of pain even after full conduction block has occurred; hence, general anesthetics and/or analgesics must also be given to prevent anesthesia awareness."@en . . . . . "1123548070"^^ . . "Els blocadors neuromusculars s\u00F3n subst\u00E0ncies que inhibeixen la contracci\u00F3 de la fibra muscular estriada esquel\u00E8tica per blocatge dels receptors nicot\u00EDnics a nivell de la . Tamb\u00E9 s\u00F3n anomenats relaxants musculars."@ca . . . . . . . . . . . . . . . . . . "43422"^^ . . . . . . . . . . . . . . . . . . "Bloccante neuromuscolare"@it . . . . . . . . . . . . . . .